Oakwood Labs

Oakwood offers end-to-end solutions to support all phases of long acting injectable (LAI) development with the use of our in-house Chroniject technology. Our technology enables tunable release profiles from 1 week up to 1 year. We have encapsulated a variety of molecule types. 

As an experienced CDMO partner we offer expertise from feasibility assessment, scale-up, technology transfer, and aseptic manufacturing of clinical and commercial supply. In addition we offer full analytical method development and stability services.